• Keeping up to Date with Excipients

    In a constantly changing industry, education is essential. Fortunately, communication technology has evolved along with drug development and manufacturing practices. IPEC-Americas off ers educational opportunities in regulatory requirements, good manufacturing practices (GMP), and excipient science for excipient makers and users. It delivers its content in multiple modalities: webinars (live and recorded), workshops (in-person, remote, and on-site); guides and position papers; infographics; and ... read more
  • Microplastics: Proposed EU Rules on Small Particles Could Lead to Big Implications

    Less than 100 years after the dawn of plastics in the 1950s, its tiny byproducts can be found on every continent and in every ocean. Studies are showing that microplastics—defined as any solid synthetic polymer particle with a size read more
  • Boosting Bioavailability: Micronization can Increase Oral Uptake and Improve Solubility

    Call it the “oral paradox”: oral drug delivery dominates medicine administration because it is convenient and non-invasive. But that delivery often offers poor oral bioavailability. Developing more bioavailable formulations remains a challenge to scientists creating new oral dosage forms. read more
  • Excipient Evolution: Past and Future Innovations Spur the Field, but Potential Regulations Loom Large

    Excipients are one of the anomalies of the pharmaceutical sciences. They are inactive; they are not intended to treat a disease or medical condition; yet, without excipients, the therapeutic advances of the last 100 years or so would not have happened. Excipients are a vital part of modern medicine. They help convert bulk active drugs (APIs) into medicinal products that the patient can benefit from because, unformulated, most APIs are not particularly convenient for patients. read more